GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 29.79
-0.78 (-2.55%)
At close: Sep 11, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 12.19 billion as of September 11, 2026. Its market cap has increased by 57.27% in one year.
Market Cap
12.19B
Enterprise Value
11.27B
Revenue
878.13M
Ranking
n/a
PE Ratio
65.96
Stock Price
29.79
ChartMarket Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 12.19B, an increase of 60.70%. That is a compound annual growth rate of 11.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 12.19B | 93.55% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 13.97B |
| Jinyu Bio-technology | 13.54B |
| HitGen | 12.98B |
| Shanghai Medicilon | 12.72B |
| Sino Biological,Inc. | 12.12B |
| Chengdu Olymvax Biopharmaceuticals | 11.83B |
| Inner Mongolia Furui Medical Science | 11.73B |
| Chengzhi | 11.50B |